SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Benden C)
 

Search: WFRF:(Benden C) > (2018) > Lung transplantatio...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Greer, M. (author)

Lung transplantation after allogeneic stem cell transplantation: a pan-European experience

  • Article/chapterEnglish2018

Publisher, publication year, extent ...

  • 2018-02-14
  • European Respiratory Society (ERS),2018

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/268233
  • https://gup.ub.gu.se/publication/268233URI
  • https://doi.org/10.1183/13993003.01330-2017DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transplantation (SCT) recipients within 5 years, conferring subsequent 5-year survival of 50%. Lung transplantation is rarely performed in this setting due to concomitant extrapulmonary morbidity, excessive immunosuppression and concerns about recurring malignancy being considered contraindications. This study assesses survival in highly selected patients undergoing lung transplantation for LONIPCs after SCT. SCT patients undergoing lung transplantation at 20 European centres between 1996 and 2014 were included. Clinical data pre- and post-lung transplantation were reviewed. Propensity score-matched controls were generated from the Eurotransplant and Scandiatransplant registries. Kaplan-Meier survival analysis and Cox proportional hazard regression models evaluating predictors of graft loss were performed. Graft survival at 1, 3 and 5 years of 84%, 72% and 67%, respectively, among the 105 SCT patients proved comparable to controls (p=0.75). Sepsis accounted for 15 out of 37 deaths (41%), with prior mechanical ventilation (HR 6.9, 95% CI 1.0-46.7; p<0.001) the leading risk factor. No SCT-specific risk factors were identified. Recurring malignancy occurred in four patients (4%). Lung transplantation <2 years post-SCT increased all-cause 1-year mortality (HR 7.5, 95% CI 2.3-23.8; p=0.001). Lung transplantation outcomes following SCT were comparable to other end-stage diseases. Lung transplantation should be considered feasible in selected candidates. No SCT-specific factors influencing outcome were identified within this carefully selected patient cohort.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Berastegui, C. (author)
  • Jaksch, P. (author)
  • Benden, C. (author)
  • Aubert, J. (author)
  • Roux, A. (author)
  • Lhuillier, E. (author)
  • Hirschi, S. (author)
  • Reynaud-Gaubert, M. (author)
  • Philit, F. (author)
  • Claustre, J. (author)
  • LePalud, P. (author)
  • Stern, M. (author)
  • Knoop, C. (author)
  • Vos, R. (author)
  • Verschuuren, E. (author)
  • Fisher, A. (author)
  • Riise, G. (author)
  • Hansson, L. (author)
  • Iversen, M. (author)
  • Hammainen, P. (author)
  • Wedel, HansGothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för hälsometri,Institute of Medicine, Department of Public Health and Community Medicine, Health Metrics(Swepub:gu)xwedha (author)
  • Smits, J. (author)
  • Gottlieb, J. (author)
  • Holm, A. M. (author)
  • Lhoon Jh, Chest V. P. (author)
  • Göteborgs universitetInstitutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för hälsometri (creator_code:org_t)

Related titles

  • In:European Respiratory Journal: European Respiratory Society (ERS)51:20903-19361399-3003

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view